XML 119 R105.htm IDEA: XBRL DOCUMENT v3.19.2
Selected Quarterly Financial Data (Schedule Of Quarterly Financial Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Quarterly Financial Information Disclosure [Abstract]                      
Net Sales $ 323,670 $ 317,882 $ 349,581 $ 316,654 $ 308,170 $ 296,174 $ 319,665 $ 298,916 $ 1,307,787 [1],[2] $ 1,222,925 [1],[2] $ 1,201,842 [1],[2]
Gross Profit 78,210 75,397 91,392 81,199 76,181 67,911 83,939 75,475 326,198 303,506 318,780
Net Income $ 33,010 [3],[4] $ 30,604 $ 47,907 [4] $ 39,028 $ 32,387 $ 27,621 $ 45,920 [5] $ 29,386 $ 150,549 [3],[4] $ 135,314 [5] $ 115,314
Diluted Net Income Per Common Share (in dollars per share) $ 1.20 [3],[4],[6] $ 1.11 [6] $ 1.73 [4],[6] $ 1.42 [6] $ 1.18 [6] $ 1.00 [6] $ 1.67 [5],[6] $ 1.07 [6] $ 5.46 [3],[4],[6] $ 4.92 [5],[6] $ 4.20
Fair Value Adjustment [Member]                      
Interim Period, Costs Not Allocable [Line Items]                      
Quarterly charges and (credits), amount affecting comparability $ (5,700)   $ (7,400)           $ (13,100)    
Quarterly charges and (credits), per share amount affecting comparability (in dollars per share) $ (0.21)   $ (0.27)           $ (0.48)    
ERP Expenses [Member]                      
Interim Period, Costs Not Allocable [Line Items]                      
Quarterly charges and (credits), amount affecting comparability $ 1,400               $ 1,400    
Quarterly charges and (credits), per share amount affecting comparability (in dollars per share) $ 0.05               $ 0.05    
Restructuring and Impairment Charges [Member]                      
Interim Period, Costs Not Allocable [Line Items]                      
Quarterly charges and (credits), amount affecting comparability $ 1,300               $ 1,300    
Quarterly charges and (credits), per share amount affecting comparability (in dollars per share) $ 0.05               $ 0.05    
Deferred Tax Benefit Resulting From Tax Rate Change [Member]                      
Interim Period, Costs Not Allocable [Line Items]                      
Quarterly charges and (credits), amount affecting comparability             $ (8,900)     $ (9,500)  
Quarterly charges and (credits), per share amount affecting comparability (in dollars per share)             $ (0.32)     $ (0.35)  
[1] All intercompany transactions have been eliminated.
[2] Net sales and long-lived assets are predominately domestic.
[3] Included in the fourth quarter and fiscal year net income were after-tax ERP expenses of $1.4 million, or approximately $0.05 per diluted share, and after-tax restructuring and impairment charges of $1.3 million, or approximately $0.05 per diluted share.
[4] Included in the second quarter and fourth quarter net income was an after-tax benefit of $7.4 million and $5.7 million, respectively, or approximately $0.27 and $0.21 per diluted share, respectively, related to the reduction in the fair value of Angelic’s contingent consideration liability. The after-tax benefit for the fiscal year was $13.1 million, or approximately $0.48 per diluted share.
[5] Included in the second quarter net income was the one-time preliminary deferred tax benefit of $8.9 million, or approximately $0.32 per diluted share, resulting from the Tax Act. The fiscal year impact was $9.5 million, or approximately $0.35 per diluted share.
[6] Diluted net income per common share amounts are calculated independently for each of the quarters presented. Accordingly, the sum of the quarterly net income per common share amounts may not agree with the fiscal year.